A randomized, double-blind, placebo-controlled crossover study of α4β 2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder

Authors: Aurelija Jucaite, John Öhd, Alexandra S Potter, Judith Jaeger, Pär Karlsson, Kristin Hannesdottir, Emma Boström, Paul A Newhouse, Björn Paulsson

Journal: Psychopharmacology

Year Published: 2014

Rationale: Stimulation of nicotinic cholinergic systems has been shown to alleviate ADHD symptoms and to improve cognitive performance. AZD1446 is a selective α4β2* nicotinic acetylcholine receptor agonist with potential effect on the symptoms of ADHD. Objectives: […]

Back to Publications